18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Neutrophils are a component of the tumor microenvironment and have been predominantly associated with cancer progression. Using a genetic approach complemented by adoptive transfer, we found that neutrophils are essential for resistance against primary 3-methylcholantrene-induced carcinogenesis. Neutrophils were essential for the activation of an interferon-γ-dependent pathway of immune resistance, associated with polarization of a subset of CD4 CD8 unconventional αβ T cells (UTC αβ). Bulk and single-cell RNA sequencing (scRNA-seq) analyses unveiled the innate-like features and diversity of UTC αβ associated with neutrophil-dependent anti-sarcoma immunity. In selected human tumors, including undifferentiated pleomorphic sarcoma, CSF3R expression, a neutrophil signature and neutrophil infiltration were associated with a type 1 immune response and better clinical outcome. Thus, neutrophils driving UTC αβ polarization and type 1 immunity are essential for resistance against murine sarcomas and selected human tumors.

          Graphical Abstract

          Highlights

          • Neutrophils mediate antitumor response by sustaining an IL-12/IFNγ-dependent pathway

          • Neutrophils are essential for unconventional αβ T cell (UTCαβ) type 1 polarization

          • Type 1 UTC αβ possess an innate-like phenotype and display antitumor potential in vivo

          • Neutrophil infiltration is associated with good prognosis in selected human tumors

          Abstract

          Tumor-associated neutrophils (TANs) have mainly been portrayed as tumor-promoters. Here, we describe a novel antitumor pathway in which TANs promote IL-12 production by macrophages, leading to type 1 polarization of a subset of unconventional αβ T cell (UTC αβ). Type 1 UTC αβ possess an innate-like phenotype and antitumor potential in vivo. In selected human tumors, neutrophil infiltration is associated with type 1 immunity and better clinical outcome.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Neutrophils in cancer: neutral no more.

          Neutrophils are indispensable antagonists of microbial infection and facilitators of wound healing. In the cancer setting, a newfound appreciation for neutrophils has come into view. The traditionally held belief that neutrophils are inert bystanders is being challenged by the recent literature. Emerging evidence indicates that tumours manipulate neutrophils, sometimes early in their differentiation process, to create diverse phenotypic and functional polarization states able to alter tumour behaviour. In this Review, we discuss the involvement of neutrophils in cancer initiation and progression, and their potential as clinical biomarkers and therapeutic targets.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

            Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance' process that protects immunocompetent hosts against primary tumour development, but this idea was largely abandoned when no differences in primary tumour development were found between athymic nude mice and syngeneic wild-type mice. However, subsequent observations that nude mice do not completely lack functional T cells and that two components of the immune system-IFNgamma and perforin-help to prevent tumour formation in mice have led to renewed interest in a tumour-suppressor role for the immune response. Here we show that lymphocytes and IFNgamma collaborate to protect against development of carcinogen-induced sarcomas and spontaneous epithelial carcinomas and also to select for tumour cells with reduced immunogenicity. The immune response thus functions as an effective extrinsic tumour-suppressor system. However, this process also leads to the immunoselection of tumour cells that are more capable of surviving in an immunocompetent host, which explains the apparent paradox of tumour formation in immunologically intact individuals.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

              Tumor immune cell compositions play a major role in response to immunotherapy, but the heterogeneity and dynamics of immune infiltrates in human cancer lesions remain poorly characterized. Here, we identify conserved intratumoral CD4 and CD8 T cell behaviors in scRNA-seq data from 25 melanoma patients. We discover a large population of CD8 T cells showing continuous progression from an early effector "transitional" into a dysfunctional T cell state. CD8 T cells that express a complete cytotoxic gene set are rare, and TCR sharing data suggest their independence from the transitional and dysfunctional cell states. Notably, we demonstrate that dysfunctional T cells are the major intratumoral proliferating immune cell compartment and that the intensity of the dysfunctional signature is associated with tumor reactivity. Our data demonstrate that CD8 T cells previously defined as exhausted are in fact a highly proliferating, clonal, and dynamically differentiating cell population within the human tumor microenvironment.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell
                Cell
                Cell
                Cell Press
                0092-8674
                1097-4172
                11 July 2019
                11 July 2019
                : 178
                : 2
                : 346-360.e24
                Affiliations
                [1 ]Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy
                [2 ]Humanitas Clinical and Research Center, 20089 Rozzano, Italy
                [3 ]Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA
                [4 ]Institute of Genetic and Biomedical Research, UoS Milan, National Research Council, 20089 Rozzano, Italy
                [5 ]Surgical Oncology Unit, Humanitas Clinical and Research Center, Via Manzoni 56, 20089 Rozzano, Italy
                [6 ]Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy
                [7 ]Zoology Department College of Science, King Saud University, 12372 Riyadh, Saudi Arabia
                [8 ]Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4GT, UK
                [9 ]Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80138 Naples, Italy
                [10 ]The William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK
                Author notes
                [∗∗ ]Corresponding author sebastien.jaillon@ 123456humanitasresearch.it
                [11]

                These authors contributed equally

                [12]

                Lead Contact

                Article
                S0092-8674(19)30618-X
                10.1016/j.cell.2019.05.047
                6630709
                31257026
                8243cad1-0e8c-4434-9042-1937b066333b
                © 2019 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 29 January 2019
                : 15 April 2019
                : 22 May 2019
                Categories
                Article

                Cell biology
                neutrophils,tumor immunology,unconventional t cells,soft tissue sarcomas,innate immunity,carcinogenesis,interleukin-12,macrophages

                Comments

                Comment on this article